Impact of the 2023 ACR/EULAR classification criteria in pregnant women with primary antiphospholipid syndrome: insights from a Portuguese cohort
ARP Rheumatology · 2026
DOI: 10.63032/pyat3103 ↗Kurz gefasst
Fachartikel in der Zeitschrift ARP Rheumatology, 2026. Verfasst von Ana Rita Lopes und 7 weiteren Autor:innen. Beteiligte Einrichtung: ULS Santa Maria, Lisbon Academic Medical Center, Lisbon. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Pregnancy Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- ULS Santa Maria, Lisbon Academic Medical Center, Lisbon.
Zitieren
APA
Lopes, A. R., Martins, C., Barreira, S., Martins, P., Pulido-Valente, M., Pinto, L., Capela, S., & Cruz-Machado, A. R. (2026). Impact of the 2023 ACR/EULAR classification criteria in pregnant women with primary antiphospholipid syndrome: insights from a Portuguese cohort. ARP Rheumatology. https://doi.org/10.63032/pyat3103
Vancouver
Lopes AR, Martins C, Barreira S, Martins P, Pulido-Valente M, Pinto L, et al. Impact of the 2023 ACR/EULAR classification criteria in pregnant women with primary antiphospholipid syndrome: insights from a Portuguese cohort. ARP Rheumatology. 2026. doi:10.63032/pyat3103
BibTeX
@article{Lopes2026,
author = {Lopes, Ana Rita and Martins, Carla and Barreira, Sofia and Martins, Patrícia and Pulido-Valente, Maria and Pinto, Luísa and Capela, Susana and Cruz-Machado, Ana Rita},
title = {Impact of the 2023 ACR/EULAR classification criteria in pregnant women with primary antiphospholipid syndrome: insights from a Portuguese cohort},
journal = {ARP Rheumatology},
year = {2026},
doi = {10.63032/pyat3103}
}
EUVIMED